<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04003337</url>
  </required_header>
  <id_info>
    <org_study_id>EmbryoSEL</org_study_id>
    <nct_id>NCT04003337</nct_id>
  </id_info>
  <brief_title>Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation.</brief_title>
  <acronym>EmbryoSEL</acronym>
  <official_title>Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation. Prospective and Randomized Trial of Patients Using Time-lapse (Embryoscope®).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procreatec</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Espanola Fertilidad</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Procreatec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study intends to demonstrate that the selection of an embryo to transfer it at the sage
      of blastocyst through morphokinetics (analysis of embryos depending not only in their
      morphology —that is, the aspect of the embryo—, but also based on times of cell division)
      during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as
      selection is not performed in mere morphological evolution (visual aspect of the embryo) of
      the embryos.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our study intends to demonstrate that the selection of an embryo to transfer it at the sage
      of blastocyst through morphokinetics (analysis of embryos depending not only in their
      morphology —that is, the aspect of the embryo—, but also based on times of cell division)
      during the use of time-lapse (Embryoscope®) may have a better impact in clinical results, as
      selection is not performed in mere morphological evolution (visual aspect of the embryo) of
      the embryos.

      In order to obtain this objective, patients participating in the study will be randomly
      assigned to one of the following groups:

      Group A: Patients who will perform an embryo transfer of a blastocyst using morphological
      criteria to evaluate que quality of the blastocyst (Gardner Classification), that is, based
      on the aspect or form of the embryo.

      Group B: Patients who will perform an embryo transfer of a blastocyst using morphokinetics
      criteria to evaluate the quality of the blastocyst (Embryoscope®), that is, based not only in
      the aspect of the embryo but also in cell division times experimented by the embryos.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two arms interventional prospective randomized controlled trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Once patients accept to be enrolled in the study, one of the nurses will allocate the patient to one of study groups. Neither the patient nor the doctor will know the group assigned.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>12-14 days after the embryo transfer</time_frame>
    <description>Positive pregnancy test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>12-15 days after the positive blood test for pregnancy</time_frame>
    <description>US pregnancy confirmation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Embryo Implantation</condition>
  <arm_group>
    <arm_group_label>GROUP A: Morphological embryo selection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients enrolled in group A will receive an embryo transfer according to classical morphological criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B: Morpho-kinetics embryo selection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients enrolled in group B will receive an embryo transfer according to new morphokinetics criteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Morpho-kinetics selection with time-lapse (Embryoscope) evaluation</intervention_name>
    <description>Embryos in group B will be selected in blastocyst stage according to morpho-kinetics criteria before the embryo transfer</description>
    <arm_group_label>GROUP B: Morpho-kinetics embryo selection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Egg-donation IVF patients

          -  IVF patients if &lt; 38 years

          -  Sperm concentration &gt; 2 million/ml

          -  Frozen eggs for

          -  Single embryo transfer

          -  ICSI fertilization

        Exclusion Criteria:

          -  Uterine pathologies that may interfere with implantation

          -  Endometriosis

          -  Frozen eggs

          -  Pre implantation genetic testing of the embryos

          -  Day 3 embryo transfer

          -  Conventional IVF treatments
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lourdes Lopez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Procreatec</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ester Padilla</last_name>
    <phone>0034914585804</phone>
    <phone_ext>24</phone_ext>
    <email>esterpadilla@procreatec.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lourdes Lopez</last_name>
    <phone>0034914585804</phone>
    <email>lopezyanez@procreatec.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Procreatec</name>
      <address>
        <city>Madrid</city>
        <zip>28036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lourdes Lopez, MD</last_name>
      <phone>0034914585804</phone>
      <email>lopezyanez@procreatec.com</email>
    </contact>
    <contact_backup>
      <last_name>Katharina Spies, MD</last_name>
      <phone>0034914585804</phone>
      <phone_ext>28</phone_ext>
      <email>katharina.spies@procreatec.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

